Seungwon An1, Ilangovan Raju1, Bayasgalan Surenkhuu1, Ji-Eun Kwon1, Shilpa Gulati1, Muge Karaman2, Anubhav Pradeep1, Satyabrata Sinha3, Christine Mun1, Sandeep Jain4. 1. Cornea Translational Biology Laboratory, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL, 60612, USA. 2. Department of Bioengineering, University of Illinois at Chicago, Chicago, IL, 60612, USA. 3. Cole Eye Institute, Cleveland Clinic, Cleveland, OH, 44195, USA. 4. Cornea Translational Biology Laboratory, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL, 60612, USA. Electronic address: jains@uic.edu.
Abstract
PURPOSE: To investigate the role of neutrophil extracellular traps (NETs) and NET-associated proteins in the pathogenesis of oGVHD and whether dismantling of NETs with heparin reduces those changes. METHODS: Ocular surface washings from oGVHD patients and healthy subjects were analyzed. Isolated peripheral blood human neutrophils were stimulated to generate NETs and heparinized NETs. We performed in vitro experiments using cell lines (corneal epithelial, conjunctival fibroblast, meibomian gland (MG) epithelial and T cells), and in vivo experiments using murine models, and compared the effects of NETs, heparinized NETs, NET-associated proteins and neutralizing antibodies to NET-associated proteins. RESULTS: Neutrophils, exfoliated epithelial cells, NETs and NET-associated proteins (extracellular DNA, Neutrophil Elastase, Myeloperoxidase, Oncostatin M (OSM), Neutrophil gelatinase-associated lipocalin (NGAL) and LIGHT/TNFSF14) are present in ocular surface washings (OSW) and mucocellular aggregates (MCA). Eyes with high number of neutrophils in OSW have more severe signs and symptoms of oGVHD. NETs (and OSM) cause epitheliopathy in murine corneas. NETs (and LIGHT/TNFSF14) increase proliferation of T cells. NETs (and NGAL) inhibit proliferation and differentiation of MG epithelial cells. NETs enhance proliferation and myofibroblast transformation of conjunctival fibroblasts. Sub-anticoagulant dose Heparin (100 IU/mL) dismantles NETs and reduces epithelial, fibroblast, T cell and MG cell changes induced by NETs. CONCLUSION: NETs and NET-associated proteins contribute to the pathological changes of oGVHD (corneal epitheliopathy, conjunctival cicatrization, ocular surface inflammation and meibomian gland disease). Our data points to the potential of NET-associated proteins (OSM or LIGHT/TNFSF14) to serve as biomarkers and NET-dismantling biologics (heparin eye drops) as treatment for oGVHD.
PURPOSE: To investigate the role of neutrophil extracellular traps (NETs) and NET-associated proteins in the pathogenesis of oGVHD and whether dismantling of NETs with heparin reduces those changes. METHODS: Ocular surface washings from oGVHD patients and healthy subjects were analyzed. Isolated peripheral blood human neutrophils were stimulated to generate NETs and heparinized NETs. We performed in vitro experiments using cell lines (corneal epithelial, conjunctival fibroblast, meibomian gland (MG) epithelial and T cells), and in vivo experiments using murine models, and compared the effects of NETs, heparinized NETs, NET-associated proteins and neutralizing antibodies to NET-associated proteins. RESULTS: Neutrophils, exfoliated epithelial cells, NETs and NET-associated proteins (extracellular DNA, Neutrophil Elastase, Myeloperoxidase, Oncostatin M (OSM), Neutrophil gelatinase-associated lipocalin (NGAL) and LIGHT/TNFSF14) are present in ocular surface washings (OSW) and mucocellular aggregates (MCA). Eyes with high number of neutrophils in OSW have more severe signs and symptoms of oGVHD. NETs (and OSM) cause epitheliopathy in murine corneas. NETs (and LIGHT/TNFSF14) increase proliferation of T cells. NETs (and NGAL) inhibit proliferation and differentiation of MG epithelial cells. NETs enhance proliferation and myofibroblast transformation of conjunctival fibroblasts. Sub-anticoagulant dose Heparin (100 IU/mL) dismantles NETs and reduces epithelial, fibroblast, T cell and MG cell changes induced by NETs. CONCLUSION: NETs and NET-associated proteins contribute to the pathological changes of oGVHD (corneal epitheliopathy, conjunctival cicatrization, ocular surface inflammation and meibomian gland disease). Our data points to the potential of NET-associated proteins (OSM or LIGHT/TNFSF14) to serve as biomarkers and NET-dismantling biologics (heparin eye drops) as treatment for oGVHD.
Authors: K Tamada; K Shimozaki; A I Chapoval; G Zhu; G Sica; D Flies; T Boone; H Hsu; Y X Fu; S Nagata; J Ni; L Chen Journal: Nat Med Date: 2000-03 Impact factor: 53.440
Authors: J A Harrop; M Reddy; K Dede; M Brigham-Burke; S Lyn; K B Tan; C Silverman; C Eichman; R DiPrinzio; J Spampanato; T Porter; S Holmes; P R Young; A Truneh Journal: J Immunol Date: 1998-08-15 Impact factor: 5.422
Authors: O Lider; Y A Mekori; T Miller; R Bar-Tana; I Vlodavsky; E Baharav; I R Cohen; Y Naparstek Journal: Eur J Immunol Date: 1990-03 Impact factor: 5.532
Authors: Kathryn L Pothoven; James E Norton; Lydia A Suh; Roderick G Carter; Kathleen E Harris; Assel Biyasheva; Kevin Welch; Stephanie Shintani-Smith; David B Conley; Mark C Liu; Atsushi Kato; Pedro C Avila; Qutayba Hamid; Leslie C Grammer; Anju T Peters; Robert C Kern; Bruce K Tan; Robert P Schleimer Journal: J Allergy Clin Immunol Date: 2016-12-18 Impact factor: 10.793
Authors: Alison J Dicker; Megan L Crichton; Eleanor G Pumphrey; Andrew J Cassidy; Guillermo Suarez-Cuartin; Oriol Sibila; Elizabeth Furrie; Christopher J Fong; Wasyla Ibrahim; Gill Brady; Gisli G Einarsson; J Stuart Elborn; Stuart Schembri; Sara E Marshall; Colin N A Palmer; James D Chalmers Journal: J Allergy Clin Immunol Date: 2017-05-13 Impact factor: 10.793
Authors: Daniel Wolff; Vedran Radojcic; Robert Lafyatis; Resat Cinar; Rachel K Rosenstein; Edward W Cowen; Guang-Shing Cheng; Ajay Sheshadri; Anne Bergeron; Kirsten M Williams; Jamie L Todd; Takanori Teshima; Geoffrey D E Cuvelier; Ernst Holler; Shannon R McCurdy; Robert R Jenq; Alan M Hanash; David Jacobsohn; Bianca D Santomasso; Sandeep Jain; Yoko Ogawa; Philipp Steven; Zhonghui Katie Luo; Tina Dietrich-Ntoukas; Daniel Saban; Ervina Bilic; Olaf Penack; Linda M Griffith; Meredith Cowden; Paul J Martin; Hildegard T Greinix; Stefanie Sarantopoulos; Gerard Socie; Bruce R Blazar; Joseph Pidala; Carrie L Kitko; Daniel R Couriel; Corey Cutler; Kirk R Schultz; Steven Z Pavletic; Stephanie J Lee; Sophie Paczesny Journal: Transplant Cell Ther Date: 2021-06-10
Authors: Leonie Fingerhut; Bernhard Ohnesorge; Myriam von Borstel; Ariane Schumski; Katrin Strutzberg-Minder; Matthias Mörgelin; Cornelia A Deeg; Henk P Haagsman; Andreas Beineke; Maren von Köckritz-Blickwede; Nicole de Buhr Journal: Cells Date: 2019-11-27 Impact factor: 6.600